Invention Grant
- Patent Title: Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
-
Application No.: US16127832Application Date: 2018-09-11
-
Publication No.: US10548857B2Publication Date: 2020-02-04
- Inventor: Herriot Tabuteau
- Applicant: ANTECIP BIOVENTURES II LLC
- Applicant Address: US NY New York
- Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee Address: US NY New York
- Agency: Maschoff Brennan
- Agent Brent A. Johnson; Yuefen Zhou
- Main IPC: A61K31/137
- IPC: A61K31/137 ; A61K31/485 ; A61K31/4748 ; A61K9/00
Abstract:
This disclosure relates to methods administering various compounds in conjunction with dextromethorphan to a human being. Dosage forms, drug delivery systems, and methods related to dextromethorphan or dextrorphan and bupropion, hydroxybupropion, erythrohydroxybupropion, threohydroxybupropion, or a metabolite or prodrug of any of these compounds are also disclosed.
Public/Granted literature
Information query
